OnabotulinumtoxinA in the treatment of neurogenic bladder
Aziz Gulamhusein, Altaf MangeraDepartment of Urology Research, Sheffield Teaching Hospitals NHS Trust, Royal Hallamshire Hospital, Sheffield, United KingdomAbstract: This review examines the evidence for use of onabotulinumtoxinA in the treatment of neurogenic lower urinary tract dysfunction. Since...
Guardado en:
Autores principales: | Gulamhusein A, Mangera A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fb955cee469248cdbbf9caff8b788a89 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
[7] Efficacy, complications and tolerability of repeated intravesical onabotulinumtoxinA injections in interstitial cystitis/bladder pain syndrome
por: Riyad Al Mousa, et al.
Publicado: (2018) -
Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine
por: Robertson CE, et al.
Publicado: (2012) -
Comparison of VATS and Thoracotomy Results in Mediastinal Neurogenic Tumors
por: Ali Bilal Ulas, et al.
Publicado: (2021) -
Assessment of hydroalcoholic extract of Thymus Vulgaris on neurogenic and inflammatory pain in mice
por: AA Taherian, et al.
Publicado: (2005) -
Neurogenic Bladder Dysfunction in Cancer Patients after Operations on the Pelvic Organs
por: V. F. Onopko, et al.
Publicado: (2019)